全文获取类型
收费全文 | 15254篇 |
免费 | 1379篇 |
国内免费 | 347篇 |
专业分类
耳鼻咽喉 | 88篇 |
儿科学 | 282篇 |
妇产科学 | 462篇 |
基础医学 | 908篇 |
口腔科学 | 614篇 |
临床医学 | 2283篇 |
内科学 | 2168篇 |
皮肤病学 | 339篇 |
神经病学 | 830篇 |
特种医学 | 217篇 |
外国民族医学 | 3篇 |
外科学 | 1576篇 |
综合类 | 1565篇 |
预防医学 | 1191篇 |
眼科学 | 140篇 |
药学 | 1895篇 |
4篇 | |
中国医学 | 1820篇 |
肿瘤学 | 595篇 |
出版年
2024年 | 45篇 |
2023年 | 417篇 |
2022年 | 527篇 |
2021年 | 876篇 |
2020年 | 733篇 |
2019年 | 780篇 |
2018年 | 743篇 |
2017年 | 671篇 |
2016年 | 552篇 |
2015年 | 573篇 |
2014年 | 1492篇 |
2013年 | 1527篇 |
2012年 | 976篇 |
2011年 | 916篇 |
2010年 | 739篇 |
2009年 | 704篇 |
2008年 | 702篇 |
2007年 | 648篇 |
2006年 | 606篇 |
2005年 | 535篇 |
2004年 | 445篇 |
2003年 | 304篇 |
2002年 | 283篇 |
2001年 | 209篇 |
2000年 | 156篇 |
1999年 | 133篇 |
1998年 | 114篇 |
1997年 | 82篇 |
1996年 | 75篇 |
1995年 | 44篇 |
1994年 | 59篇 |
1993年 | 32篇 |
1992年 | 30篇 |
1991年 | 33篇 |
1990年 | 33篇 |
1989年 | 35篇 |
1988年 | 22篇 |
1987年 | 21篇 |
1986年 | 11篇 |
1985年 | 20篇 |
1984年 | 14篇 |
1983年 | 12篇 |
1982年 | 6篇 |
1981年 | 12篇 |
1980年 | 4篇 |
1979年 | 8篇 |
1976年 | 4篇 |
1975年 | 4篇 |
1973年 | 4篇 |
1971年 | 3篇 |
排序方式: 共有10000条查询结果,搜索用时 562 毫秒
81.
D. J. King M. Blomqvist S. J. Cooper M. M. Doherty M. J. Mitchell R. C. Montgomery 《Psychopharmacology》1992,107(2-3):175-179
Sixty-two DSM III chronic schizophrenic inpatients were selected for a double-blind, placebo controlled, multi-centre, relapse prevention study of remoxipride, a selective dopamine (D2)-receptor antagonist. After a 1 month placebo washout, 23 patients had relapsed and were withdrawn. Of the remaining patients 19 were randomised to remoxipride (150–300 mg daily) and 20 to placebo. Their median age was 58 years, 26 were male, and the median duration of illness was 33 years. After 24 weeks a further total of 8 remoxipride and 17 placebo patients had been withdrawn. Excluding three patients withdrawn for reasons other than relapse, the comparative relapse rates were 37% and 75%, respectively (P=0.015). Efficacy analyses using clinical global impression (P=0.04) and change in BPRS scores (P=0.016) were in favour of remoxipride. Extrapyramidal symptoms were minimal in both groups. Treatment emergent adverse events were similar in the two groups. Remoxipride is therefore of potential value as a safe drug which is both effective and well tolerated in the long term management of chronic schizophrenic patients. 相似文献
82.
MGC Hendriks P Dogterom JT Ebels B Oosterhuis LR Geertsema T Hulot G Bianchetti and JHG Jonkman 《Fundamental & clinical pharmacology》1998,12(5):559-565
Summary— In the present study we have compared the steady state biopharmaceutic characteristics of four diltiazem once daily controlled release capsules: Mono-Tildiem LP 300® (300 mg), Adizem® XL (300 mg)1, Cardizem® (300 mg) and Dilacor® (240 mg). Sixteen healthy male volunteers (aged 22.9 ± 3.3 years, range 19–31 years) completed an open label, multiple oral dose, randomized, four-period crossover study without a washout period in between. The volunteers received each diltiazem formulation once daily for four days. Trough diltiazem and metabolites plasma concentrations were determined on days 3 and 4. The 24-h plasma concentration-time profiles were assessed after the dose on day 4 of each period. The following steady state pharmacokinetic parameters for diltiazem were calculated: the minimum plasma concentration (cmin), the maximum plasma concentration (cmax), the time to reach that concentration (tmax), the time interval during which the plasma concentration exceeds 50% of cmax (t50), the area under the plasma concentration-time curve (AUC72–96) and the peak-to-trough fluctuation (PTF). For the metabolites of diltiazem, N-mono-desmethyl-diltiazem (NDM) and desacetyldiltiazem (DAD), AUC72–96 (AUCNDM and AUCDAD) and the ratio metabolite/parent compound were calculated. Steady state was achieved on day 3. Except one, all controlled release formulations have satisfactory controlled release properties allowing once daily administration. However, significant (P < 0.05) differences were found between the pharmacokinetic characteristics which do not allow exchange of the various formulations. Concentrations well below 50 ng·mL-1 in the morning hours were observed for Dilacor® (240 mg) and Adizem® XL (300 mg), which could be a disadvantage of these formulations as it is well-known that ischaemic events occur at a higher rate during that part of the day. The plasma concentration profiles of NDM and DAD, the major circulating metabolites, parallel the plasma concentration profiles for the parent compound. From a clinical point of view, all treatments were well tolerated. 相似文献
83.
Peter Griffiths BA RGN & Jenifer Wilson-Barnett BA MSc PhD RGN FRCN FKCL 《Journal of advanced nursing》1998,27(6):1184-1192
A literature search was conducted to identify 'nursing led in-patient units' where the nurse is the designated leader of the clinical team. The review concentrates on studies which have attempted to measure the impact of nursing-led in-patient units and reviews both the methodology and outcomes. Three major bodies of work were identified. Lydia Hall's evaluation of the Loeb Center for Nursing and Rehabilitation (USA) is reviewed in some detail. This work was the model for 'nursing beds' at the two Oxfordshire Nursing Development Units (UK) in the 1980s. Studies evaluating these centres are reviewed and reports of similar UK units discussed. A third body of work evaluates a nurse-managed critical care environment. Common features include a case mix based on nursing need with nurses having authority to admit and discharge patients. While results are generally favourable, with improved patient independence, fewer readmissions, lower mortality and cost savings reported in some or all of the studies, all studies reviewed demonstrate the difficulties of applying an experimental model to real life clinical services. Methodological limitations render firm conclusions difficult. Techniques adopted from studies in field settings, the so-called 'quasi-experiment', are advocated as a remedy, as is further study of the process of care in investigating this model of care delivery. 相似文献
84.
There are relatively few papers which prove that one nerve anastomotic agent for the facial nerve is superior to any other. Previous experiments on the division and anastomosis of the facial nerve have failed to consider the indeterminate variables involved, i.e. operator variability, controls and the reaction of the materials on normal nerve tissue. In this experiment, a variety of anastomotic agents were tested to see if the anastomotic agents themselves affected the extra-temporal facial nerve function. The absorbable suture, non-absorbable suture, glue and tube wrap used had no effect on normal nerve tissue or on the anastomosis of the sectioned facial nerve of the rat compared with simple laying together of the divided ends of the divided nerve. 相似文献
85.
86.
Open mesh versus non-mesh repair of groin hernia meta-analysis of randomized trials leased on individual patient data 总被引:1,自引:1,他引:0
Abstract
Background. The EU Hernia Trialists Collaboration was established to provide reliable evaluation of newer methods of groin hernia repair.
It involved 70 investigators in 20 countries.
Materials and methods. Twenty eligible trials (5016 participants) of open mesh vs. non-mesh groin hernia repair were identified. Meta-analysis was
performed using raw individual patient data where possible.
Results. Fewer hernia recurrences were reported after mesh repair. There were no clear differences between mesh and non-mesh groups
in complications. Overall, those in the mesh groups had a shorter hospital stay, quicker return to usual activities and less
frequent persisting pain, but individual trial results varied.
Conclusions. The review provides strong evidence that open mesh repair is associated with a reduction in the risk of recurrence of between
50% and 75%. There is also some evidence of quicker recovery and of lower rates of persisting pain following open mesh repair.
Electronic Publication 相似文献
87.
Jan Stulik Tobias Rainer Pitzen Jan Chrobok Sabine Ruffing Jörg Drumm Laurentius Sova Ravel Kucera Tomas Vyskocil Wolf Ingo Steudel 《European spine journal》2007,16(10):1689-1694
Anterior cervical plate fixation is an approved surgical technique for cervical spine stabilization in the presence of anterior
cervical instability. Rigid plate design with screws rigidly locked to the plate is widely used and is thought to provide
a better fixation for the treated spinal segment than a dynamic design in which the screws may slide when the graft is settling.
Recent biomechanical studies showed that dynamic anterior plates provide a better graft loading possibly leading to accelerated
spinal fusion with a lower incidence of implant complications. This, however, was investigated in vitro and does not necessarily
mean to be the case in vivo, as well. Thus, the two major aspects of this study were to compare the speed of bone fusion and
the rate of implant complications using either rigid- or dynamic plates. The study design is prospective, randomized, controlled,
and multi-centric, having been approved by respective ethic committees of all participating sites. One hundred and thirty-two
patients were included in this study and randomly assigned to one of the two groups, both undergoing routine level-1- or level-2
anterior cervical discectomy with autograft fusion receiving either a dynamic plate with screws being locked in ap - position
(ABC, Aesculap, Germany), or a rigid plate (CSLP, Synthes, Switzerland). Segmental mobility and implant complications were
compared after 3- and 6 months, respectively. All measurements were performed by an independent radiologist. Mobility results
after 6 months were available for 77 patients (43 ABC/34 CSLP). Mean segmental mobility for the ABC group was 1.7 mm at the
time of discharge, 1.4 mm after 3 months, and 0.8 mm after 6 months. For the CSLP- group the measurements were 1.0, 1.8, and
1.7 mm, respectively. The differences of mean segmental mobility were statistically significant between both groups after
6 months (P = 0.02). Four patients of the CSLP-group demonstrated surgical hardware complications, whereas no implant complications were
observed within the ABC-group (P = 0.0375). Dynamic plate designs provided a faster fusion of the cervical spine compared with rigid plate designs after prior
spinal surgery. Moreover, the rate of implant complications was lower within the group of patients receiving a dynamic plate.
These interim results refer to a follow-up period of 6 months after prior spinal surgery. Further investigations will be performed
2 years postoperatively. 相似文献
88.
异丙酚复合麻醉下髋关节置换术患者瑞芬太尼控制性降压的效果 总被引:2,自引:0,他引:2
目的探讨异丙酚复合麻醉下髋关节置换术患者瑞芬太尼控制性降压的效果。方法择期行髋关节置换术患者30例,ASA分级Ⅱ级或Ⅲ级,随机分为2组(n=15):瑞芬太尼组(R组)和硝普钠组(N组)。2组麻醉诱导气管插管后在30min内静脉输注6%羟乙基淀粉200/0.5 15ml/kg行急性高容量血液稀释,桡动脉穿刺置管监测平均动脉压(MAP)和心率(HR),颈内静脉穿刺置管监测中心静脉压,术中维持脑电双频谱指数45~55。2组于切皮前开始降压,R组和N组分别持续静脉输注瑞芬太尼0.3~0.7μg·kg~(-1)·min~(-1)、硝普钠0.5~6.0μg·kg~(-1)·min~(-1),使MAP降低到术前基础值的70%左右(60~70mm Hg)并维持至术毕。分别于急性高容量血液稀释后控制性降压前即刻(T_0)、控制性降压20min(T_1)、40min(T_2)、术毕(T_3)时抽取静脉血,测定血红蛋白(Hb)、红细胞压积(Hct)、乳酸(Lac)浓度,同时抽取动脉血,行动脉血气分析,记录开始降压至目标血压所需的时间(降压诱导时间)、停降压药后MAP恢复至基础值的时间(MAP恢复时间)及术中出血量、输血量。结果与N组比较,R组降压诱导时间、MAP恢复时间、血气分析指标及Lae水平差异无统计学意义(P>0.05),T_(1,2)时HR降低,出血量减少(P<0.05或0.01);N组有5例患者发生反射性心动过速,需使用艾司洛尔,T_3时有2例患者发生反跳性高血压,2组术后均未见并发症。结论异丙酚复合麻醉下髋关节置换术患者持续静脉输注瑞芬太尼0.3~0.7μg·kg~(-1)·min~(-1)控制性降压可控性好,降压及恢复平稳,且血液保护作用优于硝普钠。 相似文献
89.
家兔80只,分成4组,每组10只供心兔,10只供血兔,采用在体循环灌注离体心脏模型,对心肌缺血后不同控制性再灌注(控灌)时间对再灌注损害的影响进行了研究。结果显示:5、15和30min的控灌对心肌肌酸磷酸激酶的同工酶(CPK-MB)、含水量(MWC)、丙二醛(MDA)含量以及超微结构的影响明显优于未经控灌的实验组(P<0.05),5min和30min控灌组差异不显著(P>0.05),15min控灌组其各项指标又明显优于5min和30min控灌组。结果提示:控灌有预防缺血再灌注损伤的作用,且以15min控灌疗效最佳。 相似文献
90.
背景 上肢运动功能障碍是脑卒中后常见的后遗症之一,严重影响患者日常生活能力。重复经颅磁刺激(rTMS)作为常见的神经电生理技术对治疗脑卒中后上肢运动功能障碍有较好的疗效,但临床对不同rTMS干预模式的选择仍缺乏循证依据。目的 采用网状Meta分析方法比较rTMS的4种模式对脑卒中后上肢运动功能障碍患者的临床疗效。方法 计算机检索PubMed、Embase、Cochrane Library、Web of Science、中国生物医学文献数据库、中国知网、万方数据知识服务平台、维普网中有关rTMS治疗脑卒中后上肢运动功能障碍的随机对照试验,并通过追溯Meta分析的参考文献作为补充。检索时间均为建库至2022年2月,采用主题词和自由词结合方式进行。2名研究者进行文献筛选、资料提取及质量评价。采用RevMan 5.0软件和Stata 16.0软件进行统计学分析。结果 最终纳入17篇文献,790例患者,共涉及6种干预措施:高频rTMS(HF-rTMS)、低频rTMS(LF-rTMS)、间断性theta节律刺激(iTBS)、连续性theta节律刺激(cTBS)、假刺激、常规疗法。网状Meta分析结... 相似文献